Due to SP140’s ability to enhance STAT1/IRF1 signaling and increase PD-L1 expression in tumor-associated macrophages, it has emerged as a crucial biomarker of immune evasion and predictor of immunotherapy resistance in cancers such as HNSCC and lung cancer. Here, STAT1 is linked to lung carcinoma.